These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15311111)

  • 21. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
    Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lisinopril and diltiazem reduce left ventricular mass without changing blood pressure in normotensive subjects with exaggerated blood pressure response to exercise.
    Polónia J; Martins L; Macedo F; Faria DB; Simões L; Brandão F; Gomes MC
    Rev Port Cardiol; 1996 Mar; 15(3):185-93, 179. PubMed ID: 8634167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study.
    Gosse P; Sheridan DJ; Zannad F; Dubourg O; Guéret P; Karpov Y; de Leeuw PW; Palma-Gamiz JL; Pessina A; Motz W; Degaute JP; Chastang C
    J Hypertens; 2000 Oct; 18(10):1465-75. PubMed ID: 11057435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Three-dimensional analysis of left ventricular geometry using magnetic resonance imaging: feasibility and comparison with echocardiographic analysis].
    Moriuchi M; Saito S; Kasamaki Y; Komaki K; Kanmatsuse K; Hayasaka K
    J Cardiol; 2003 Dec; 42(6):249-60. PubMed ID: 14723017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of antihypertensive treatment on the doppler-derived myocardial performance index in patients with hypertensive left ventricular hypertrophy: results from the Swedish irbesartan in left ventricular hypertrophy investigation versus atenolol (SILVHIA).
    Liljedahl S; Kahan T; Lind L; Arnlöv J
    Echocardiography; 2009 Aug; 26(7):753-8. PubMed ID: 19486119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
    Ketelhut S; Franz IW; Ketelhut RG
    High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of spironolactone-altizide on left ventricular hypertrophy.
    Degre S; Detry JM; Unger P; Cosyns J; Brohet C; Kormoss N
    Acta Cardiol; 1998; 53(5):261-7. PubMed ID: 9922803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in left ventricular geometry during antihypertensive treatment.
    Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
    Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study.
    Cuspidi C; Muiesan ML; Valagussa L; Salvetti M; Di Biagio C; Agabiti-Rosei E; Magnani B; Zanchetti A;
    J Hypertens; 2002 Nov; 20(11):2293-300. PubMed ID: 12409969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project.
    Schneider MP; Klingbeil AU; Delles C; Ludwig M; Kolloch RE; Krekler M; Stumpe KO; Schmieder RE
    Hypertension; 2004 Jul; 44(1):61-6. PubMed ID: 15184349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of left ventricular mass between two-dimensional echocardiography, using fundamental and tissue harmonic imaging, and cardiac MRI in patients with hypertension.
    Alfakih K; Bloomer T; Bainbridge S; Bainbridge G; Ridgway J; Williams G; Sivananthan M
    Eur J Radiol; 2004 Nov; 52(2):103-9. PubMed ID: 15489067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Echocardiographic left ventricular mass in a multiethnic Southeast Asian population: proposed new gender and age-specific norms.
    Wong RC; Yip JW; Gupta A; Yang H; Ling LH
    Echocardiography; 2008 Sep; 25(8):805-11. PubMed ID: 18986407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of dual blockade of renin-angiotensin system on TGFbeta1 and left ventricular structure and function in hypertensive patients.
    Scaglione R; Argano C; Di Chiara T; Parrinello G; Colomba D; Avellone G; Donatelli M; Corrao S; Licata G
    J Hum Hypertens; 2007 Apr; 21(4):307-15. PubMed ID: 17301824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Wachtell K; Dahlöf B; Rokkedal J; Papademetriou V; Nieminen MS; Smith G; Gerdts E; Boman K; Bella JN; Devereux RB
    Am Heart J; 2002 Dec; 144(6):1057-64. PubMed ID: 12486431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.
    Okin PM; Devereux RB; Liu JE; Oikarinen L; Jern S; Kjeldsen SE; Julius S; Wachtell K; Nieminen MS; Dahlöf B
    J Hum Hypertens; 2004 Jun; 18(6):403-9. PubMed ID: 15057252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study.
    Nyström F; Malmqvist K; Ohman KP; Kahan T
    J Hypertens; 2002 Aug; 20(8):1527-33. PubMed ID: 12172314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function.
    Gottdiener JS; Livengood SV; Meyer PS; Chase GA
    J Am Coll Cardiol; 1995 Feb; 25(2):424-30. PubMed ID: 7829797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between nebivolol and ramipril in patients with hypertension and left ventricular hypertrophy: a randomized open blinded end-point (PROBE) trial.
    Cağlar N; Dincer I
    Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1359-68. PubMed ID: 22288296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study.
    Dahlöf B; Gosse P; Guéret P; Dubourg O; de Simone G; Schmieder R; Karpov Y; García-Puig J; Matos L; De Leeuw PW; Degaute JP; Magometschnigg D;
    J Hypertens; 2005 Nov; 23(11):2063-70. PubMed ID: 16208150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A reduction of left ventricular hypertrophy and an improvement in diastolic function after therapy with nifedipine retard in patients with hypertensive cardiopathy].
    Amici E; Patruno N; Natale E; Marsocci A; Gambelli G
    Cardiologia; 1993 Sep; 38(9):585-91. PubMed ID: 8287388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.